Because the donor was GALT+, successful engraftment not only treated the leukemia but also conferred normal GALT activity in RBCs (25.3 nmol/h/mg Hb, reference range > =24.5), prompting the question—Does this patient still have galactosemia? This evidence concerns the gene GSTM1 and galactosemia.